Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,680.00
+100.00 (1.79%)
At close: Aug 24, 2026

Daehan Nupharm Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
15,67715,25815,46812,54224,31715,694
Depreciation & Amortization
4,3804,3024,0983,4813,2283,330
Loss (Gain) From Sale of Assets
290.22289.840.530.53-9.510.36
Loss (Gain) From Sale of Investments
-5,992-4,511-1,281-2,5471,608290.39
Loss (Gain) on Equity Investments
133.99253.77466.76142.5326.5-
Provision & Write-off of Bad Debts
-628.99-322.052,065-19.75-762.19124.23
Other Operating Activities
385.89-352.574,2419,018131.06696.14
Change in Accounts Receivable
2,0943,015-977.64-2,190-6,059166.57
Change in Inventory
-4,999-7,219-6,858-4,136-11,599-4,803
Change in Accounts Payable
-1,8392,3992,236-1,4173,4463,346
Change in Income Taxes
---591.5-3,265-
Change in Other Net Operating Assets
-7,547-8,052-512.12-2,8993,191-2,260
Operating Cash Flow
1,9565,06118,94712,56714,25316,583
Operating Cash Flow Growth
-81.77%-73.29%50.77%-11.83%-14.05%22.42%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-43,536-50,236-33,029-9,737-3,432-10,625
Sale of Property, Plant & Equipment
5.8--0.9121.550.59
Sale (Purchase) of Intangibles
-654.89-645.39-687.67-331.24-13.51-128.68
Sale (Purchase) of Real Estate
0-187.73-568.08--82.74-269.21
Investment in Securities
-725.75-731.044,562-2,036-3,224-3,127
Other Investing Activities
--0-0-0144.28474.29
Investing Cash Flow
-45,261-52,151-29,123-12,303-6,926-13,925

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-18,78118,92723,12317,18824,442
Long-Term Debt Issued
-35,25618,831--15,800
Total Debt Issued
112,57554,03737,75823,12317,18840,242
Short-Term Debt Repaid
--14,518-15,119-19,692-12,031-35,152
Long-Term Debt Repaid
--751.05-725.77-4,310-5,418-7,834
Total Debt Repaid
-75,545-15,269-15,845-24,001-17,449-42,987
Net Debt Issued (Repaid)
37,03038,76821,913-878.16-260.42-2,745
Dividends Paid
-1,404-1,404-1,404-1,404-1,123-
Other Financing Activities
-0-0-50020
Financing Cash Flow
35,62737,36520,510-2,232-1,383-2,725

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
49.5-34.63190.7313.5-90.950.12
Miscellaneous Cash Flow Adjustments
00---00
Net Cash Flow
-7,629-9,76010,524-1,9545,853-66.3

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-41,580-45,175-14,0832,83010,8225,958
Free Cash Flow Growth
----73.85%81.63%45.96%
Free Cash Flow Margin
-20.24%-22.32%-6.97%1.39%5.47%3.58%
Free Cash Flow Per Share
-2962.55-3218.69-1003.40201.62771.04424.51
Levered Free Cash Flow
-42,638-46,138-16,0214,021-3,0115,014
Unlevered Free Cash Flow
-41,563-45,094-14,9215,122-2,2275,582

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3,4813,1872,1921,7701,235886.76
Cash Income Tax Paid
3,2324,1692,9452,7474,1859,249
Change in Working Capital
-12,290-9,856-6,112-10,050-14,286-3,551